CVKD

Cadrenal Therapeutics, Inc. CVKD

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$379.9K total
VANGUARD CAPITAL MANAGEMENT LLC
$167.5K+10.9%
HRT FINANCIAL LP
$97.0KNew
GEODE CAPITAL MANAGEMENT, LLC
$63.5K-12.0%
VANGUARD FIDUCIARY TRUST CO
$27.8K0.0%
CoreCap Advisors, LLC
$4.3KNew
Tower Research Capital LLC (TRC)
$4.3K+226.2%
UBS Group AG
$3.7KNew
Grove Bank & Trust
$3.3KNew
MORGAN STANLEY
$2.4K+606.0%
Clearstead Advisors, LLC
$2.2KNew
Quest 10 Wealth Builders, Inc.
$1.3KNew
OSAIC HOLDINGS, INC.
$1.0K0.0%
Rockefeller Capital Management L.P.
$5010.0%
WELLS FARGO & COMPANY/MN
$3310.0%
BARCLAYS PLC
$311New
Integrated Wealth Concepts LLC
$287New
Archer Investment Corp
$1170.0%
IFP Advisors, Inc
$1000.0%
Farther Finance Advisors, LLC
$840.0%
CALDWELL SUTTER CAPITAL, INC.
$170.0%
See all 20 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CVKD

Earnings Per Share

13fpro.ai/company/CVKD

Loading ratio trend…

CVKD insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Cadrenal Therapeutics, Inc. (CVKD): stock profile, AI score and financials

Cadrenal Therapeutics, Inc. (CVKD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CVKD is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of CVKD by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, HRT FINANCIAL, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. CVKD trades on the Nasdaq exchange and files with the SEC under CIK 1937993. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CVKD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cadrenal Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1937993 →